RealMind Biotech
Latest round
- Series C
Last raised
- Aug 2026
Total raised
- Undisclosed
Investors
- 2
About RealMind Biotech
, dba RealMind Biotech, is a high-tech enterprise specialized in the R&D, manufacturing and sales of in vitro diagnostic products. The company's founder, Jin Jing, holds a master's degree in biomedical engineering from Southeast University. The company has established partnerships in more than 20 countries spanning Europe, the USA, Latin America, the Middle East, Southeast Asia, and South Asia. RealMind Biotech mainly provides fully automatic chemiluminescence analyzers and related reagents, which is based on the direct chemiluminescence method of acridine lipids and supports whole blood detection. The company's products can be applied to clinical testing items such as cardiac markers, inflammation monitoring, reproductive function, growth and development, etc. The company primarily generates revenue from developing and providing chemiluminescence immunoassay systems and related reagents.
Who invested in RealMind Biotech
2 investors across 1 round
See all investors in RealMind Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Aug 20, 2026
Amount
Undisclosed
Investors
Questions about RealMind Biotech
Who invested in RealMind Biotech?
RealMind Biotech has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has RealMind Biotech raised?
RealMind Biotech has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did RealMind Biotech last raise money?
RealMind Biotech's most recent round on record is a Series C, in Aug 2026.
What does RealMind Biotech do?
, dba RealMind Biotech, is a high-tech enterprise specialized in the R&D, manufacturing and sales of in vitro diagnostic products.
Where is RealMind Biotech headquartered?
RealMind Biotech is headquartered in Nanjing, China.
Which VCs invest in companies like RealMind Biotech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at RealMind Biotech's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series C
Raising like RealMind Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.